BridgeBio Pharma Inc
NASDAQ:BBIO
BridgeBio Pharma Inc
Other Items
BridgeBio Pharma Inc
Other Items Peer Comparison
Competitive Other Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
Other Items
$67.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Items
-$10.3B
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-28%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Items
-$3.1B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Items
-$26.8B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Items
-$3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-79%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Items
-$3.8B
|
CAGR 3-Years
-212%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-32%
|
See Also
What is BridgeBio Pharma Inc's Other Items?
Other Items
67.3m
USD
Based on the financial report for Mar 31, 2024, BridgeBio Pharma Inc's Other Items amounts to 67.3m USD.
What is BridgeBio Pharma Inc's Other Items growth rate?
Other Items CAGR 1Y
-80%
Over the last year, the Other Items growth was -80%.